Lam Research Corp. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Lam Research Corporation, a provider of semiconductor manufacturing equipment, for the quarter ended December 24, 2000. The company operates in a cyclical industry dependent on capital expenditures by semiconductor manufacturers. As of the reporting date, there were 122,582,590 shares of Common Stock outstanding.
Key Financial Metrics
| Metric | Three Months Ended Dec 24, 2000 | Six Months Ended Dec 24, 2000 |
|---|---|---|
| Total Revenue | $494.3 million | $926.4 million |
| Gross Margin | $230.9 million (46.7%) | $430.2 million (46.4%) |
| Operating Income | $102.0 million | $191.8 million |
| Net Income | $73.5 million | $139.6 million |
| Diluted EPS | $0.54 | $1.02 |
| Cash & Equivalents | $141.6 million (Balance Sheet) | $141.6 million (Balance Sheet) |
| Short-term Investments | $255.6 million | $255.6 million |
| Total Debt (Current + Long-term) | $335.3 million | $335.3 million |
| Operating Cash Flow (6mo) | N/A | $108.9 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 71.3% for the quarter and 74.7% for the six-month period compared to the same periods in fiscal 2000, driven by significant growth in Etch and CMP/Clean product lines.
- Margin Expansion: Gross margin percentages improved to 46.7% (quarter) and 46.4% (six months) from 43.5% and 42.7% in the prior year, attributed to higher sales volume, lean manufacturing efficiencies, and material cost reductions.
- Expense Management: While R&D and SG&A expenses increased in absolute dollars, they decreased as a percentage of revenue due to the significant revenue growth.
- One-Time Charge: The company recognized an $8.0 million charge for the purchase of in-process research and development technology (CMP intellectual property) from Strasbaugh.
- Equity Reclassification: $52.9 million was reclassified from permanent equity to temporary equity due to compliance with EITF 00-19 regarding put option contracts.
Guidance, Outlook, and Risks
- Market Outlook: Management noted signs in the second half of the quarter that the industry upturn was slowing, with customers likely to reduce equipment purchases in the first half of calendar year 2001.
- Accounting Changes: The company is assessing the impact of SAB No. 101 on revenue recognition, which may delay revenue recognition until customer acceptance rather than shipment, potentially impacting future quarterly results. Implementation is expected in the fourth quarter of fiscal 2001.
- Liquidity: The company holds $457.5 million in cash, cash equivalents, short-term investments, and restricted cash. It has a $100 million syndicated bank line of credit with no borrowings outstanding.
- Legal Proceedings: Ongoing patent litigation with Varian Associates and Tegal Corporation. Management does not currently believe these will have a material adverse effect on financial position.
- Derivatives: The company utilizes foreign currency forward contracts to hedge Japanese Yen exposure. It also holds call and put options on its own stock to manage dilution from convertible notes.
Investor Verification Checklist
- Verify the impact of the upcoming SAB No. 101 implementation on revenue recognition timing and quarterly earnings volatility.
- Monitor the status of the semiconductor industry downturn mentioned by management and its effect on order bookings in early 2001.
- Review the details of the $52.9 million temporary equity reclassification and the terms of the associated put option contracts.
- Assess the progress and potential financial impact of the Varian and Tegal patent litigation.
- Confirm the amortization schedule and integration success of the $8.0 million Strasbaugh technology acquisition.